S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

OPGN OpGen Inc

1.96

0.00 (0.00%)

After Hours

Last Updated: 19:00:00

Delayed by 15 minutes

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

This article is 6Mb in size. Click here to view

OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more OpGen Charts.

OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more OpGen Charts.

Opgen Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 24 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 19 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Monday 19 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 19 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 August 2024 (2 months ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 14 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 August 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 1 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 8 July 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 June 2024 (4 months ago) • Edgar (US Regulatory)

More Opgen Inc News Articles

Accredited Solutions (PK)

Laser Photonics

Halozyme Therapeutics

RespireRx Pharmaceuticals (CE)

Enzolytics (PK)

Asia Broadband (PK)

TPT Global Tech (PK)

Anavex Life Sciences

Valiant Eagle (PK)

Digital Brand Media and ... (PK)

Sincerity Applied Materi... (PK)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions